Atlas Trials

Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity

Clinical trial NCT06951945 · COMPLETED

Trial details

NCT number
NCT06951945
Sponsor
Tonghua Dongbao Pharmaceutical Co.,Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Obesity
Start date
2024-07-18
Primary completion
2024-12-23
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.